SCHEMBL7654790

SCHEMBL7654790

O=C1C=CC(=O)c2cc3cc4ccccc4cc3cc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25B P30305 4/20 0.55
IDO1 P14902 3/20 0.55
PIN1 Q13526 2/20 0.55
MAOA P21397 1/20 0.55
MAOB P27338 1/20 0.55
AKT1 P31749 1/20 0.55
SNCA P37840 1/20 0.55
MAP2K1 Q02750 1/20 0.55
EHMT2 Q96KQ7 1/20 0.55
NSD1 Q96L73 1/20 0.55
EHMT1 Q9H9B1 1/20 0.55
NQO1 P15559 1/20 0.50
TOP1 P11387 2/20 0.43
ALDH1A1 P00352 6/20 0.42
HPGD P15428 5/20 0.42
TP53 P04637 4/20 0.42
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
HIF1A Q16665 3/20 0.42
MAPK1 P28482 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27549226 1.00 CDC25B (0.55) CDC25BIDO1PIN1MAOAMAOB
SCHEMBL449382 0.95 CDC25B (0.60) CDC25BIDO1PIN1MAOAMAOB
SCHEMBL29534567 0.95 CDC25B (0.60) CDC25BIDO1PIN1MAOAMAOB
Ammonia Solution, Strong SCHEMBL28326620 0.92 CDC25B (0.57) CDC25BIDO1PIN1MAOAMAOB
Naphthoquinone SCHEMBL27843680 0.90 CDC25B (0.70) CDC25BIDO1PIN1MAOAMAOB
Anthracene SCHEMBL11125352 0.87 CDC25B (0.74) CDC25BIDO1PIN1MAOAMAOB
SCHEMBL10531324 0.86 CDC25B (0.50) CDC25BIDO1PIN1MAOAMAOB
SCHEMBL10938543 0.81 IDO1 (0.50) CDC25BIDO1PIN1MAOAMAOB
SCHEMBL10057987 0.79 MEN1 (0.50) CDC25BMAOAALDH1A1HPGDTP53
SCHEMBL2516264 0.79 MEN1 (0.50) CDC25BMAOAALDH1A1HPGDTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9481618-B2 Cyclopolyarylene compound and method of manufacturing same NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) 2016-11-01 US disclosed
US-9059408-B2 Hexacene derivative, method for forming hexacene, method for forming hexacene crystal, process for making organic semiconductor device, and organic semiconductor device ACADEMIA SINICA (TW) 2015-06-16 US disclosed
US-9059408-B2 Hexacene derivative, method for forming hexacene, method for forming hexacene crystal, process for making organic semiconductor device, and organic semiconductor device ACADEMIA SINICA (TW) 2015-06-16 US disclosed
US-20140124740-A1 HEXACENE DERIVATIVE, METHOD FOR FORMING HEXACENE, METHOD FOR FORMING HEXACENE CRYSTAL, PROCESS FOR MAKING ORGANIC SEMICONDUCTOR DEVICE, AND ORGANIC SEMICONDUCTOR DEVICE ACADEMIA SINICA (TW) 2014-05-08 US disclosed
US-20140124740-A1 HEXACENE DERIVATIVE, METHOD FOR FORMING HEXACENE, METHOD FOR FORMING HEXACENE CRYSTAL, PROCESS FOR MAKING ORGANIC SEMICONDUCTOR DEVICE, AND ORGANIC SEMICONDUCTOR DEVICE ACADEMIA SINICA (TW) 2014-05-08 US disclosed
US-20140066661-A1 CYCLOPOLYARYLENE COMPOUND AND METHOD OF MANUFACTURING SAME NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) 2014-03-06 US disclosed
CN-1321965-C Anthraquinone derivative and its synthesis method UNIV TSINGHUA (CN) 2007-06-20 CN disclosed
CN-1724501-A Anthraquinone derivative and its synthesis method UNIV TSINGHUA (CN) 2006-01-25 CN disclosed
CN-1174078-C Organic electroluminescent device ������������ʽ���� 2004-11-03 CN disclosed
US-6489046-B1 CONTAINING SUCH AS 8,15-DIPHENYL OR A 8,15-BIS(BIPHENYL)-BENZO(A)PENTACENE; EMITS HIGH PURITY REDDISH LIGHT; EFFICIENT, LONG LIFE; PLANAR LIGHT EMITTING MEMBER FOR TELEVISIONS; BACK LIGHT FOR DISPLAYS IDEMITSU KOSAN CO., LTD. (JP) 2002-12-03 US disclosed
CN-1327469-A Organic electroluminescent device IDEMITSU KOSAN CO (JP) 2001-12-19 CN disclosed
EP-1138744-A1 ORGANIC ELECTROLUMINESCENT ELEMENT Idemitsu Kosan Co., Ltd. (JP) 2001-10-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140124740-A1 HEXACENE DERIVATIVE, METHOD FOR FORMING HEXACENE, METHOD FOR FORMING HEXACENE CRYSTAL, PROCESS FOR MAKING ORGANIC SEMICONDUCTOR DEVICE, AND ORGANIC SEMICONDUCTOR DEVICE XDH, HVCN1, HCN1 CDC25B 1959/4885IDO1 772/4885PIN1 756/4885
US-20140066661-A1 CYCLOPOLYARYLENE COMPOUND AND METHOD OF MANUFACTURING SAME CYP1B1, CYP51A1, CYP1A1 CDC25B 2498/4885IDO1 756/4885PIN1 509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.